I have "currently incurable" Stage IV colon cancer. I am also Ph.D. scientist in oncology drug discovery. Two of my current life missions: spread the word on the amazing advances seen in immunotherapies and eventually be cured by one!
Dr. Tom Marsilje is a dad, husband, and music lover living with stage 4 colorectal cancer. He’s also a scientist who’s spent the last 20 years in cancer research. Tom writes a monthly column for Fight Colorectal Cancer called “The Currently Incurable Scientist.” He is being treated with a combination of chemotherapies known as FOLFIRI, and the monoclonal antibody Avastin® (bevacizumab).
Sadly, Tom Marsilje passed away in November 2017.
Provide guidance and encouragement to others going through their journey with cancer immunotherapy treatment.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
More than 200 patients, caregivers, and advocates attended an Immunotherapy Patient Summit in San Diego on Saturday, June 29, 2019.
CRI hosted its inaugural “Immuno-Oncology: A Future Look” event for healthcare investment analysts and media on June 21 in New York City